A stem cell ther­a­py preps de­but in Japan­ese mar­ket to the dis­may of US re­searchers

As Japan ap­proves a stem cell treat­ment for spinal cord in­juries in a land­mark — if lit­tle no­ticed — de­ci­sion, ex­perts around the world have voiced con­cerns …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.